$105.03 B
Share price
Change (1 day)
Change (1 year)

Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.

Revenue for Medtronic (MDT)

Revenue in 2022 (TTM): $30.80 B

According to Medtronic's latest financial reports the company's current revenue (TTM) is $30.80 B. In 2021 the company made a revenue of $31.79 B an increase over the years 2020 revenue that were of $27.86 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Medtronic from 2001 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$30.80 B-3.11%
2021$31.79 B14.1%
2020$27.86 B-9.79%
2019$30.89 B1.69%
2018$30.37 B2.49%
2017$29.63 B2.16%
2016$29.01 B11.78%
2015$25.95 B49.44%
2014$17.36 B3.6%
2013$16.76 B2.73%
2012$16.31 B-0.72%
2011$16.43 B4.54%
2010$15.72 B4.17%
2009$15.09 B3.8%
2008$14.54 B15.6%
2007$12.57 B6.53%
2006$11.80 B9.7%
2005$10.76 B12.07%
2004$9.60 B15.89%
2003$8.28 B18.59%
2002$6.98 B18.33%
2001$5.90 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$96.04 B 211.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$45.03 B 46.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.74 B-52.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.56 B-59.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.36 B-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.94 B-41.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.06 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.56 B-94.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.87 B-67.96%๐Ÿ‡บ๐Ÿ‡ธ USA